CRP and infection: We found that adding a check by pharmacists of patients’ infection-related condition to a previously devised protocol, based on body temperature ≥ 37.5 °C or elevated CRP or WBC from baseline, before anticancer drug mixing significantly reduced anticancer drug wastage after mixing.